Kyndryl Holdings is trading 5.18% up now at $13.20, after rising from the August 21 close of $12.55; no clear company-specific catalyst has been identified.
- Latest releases covered a planned Healthcare IT Leaders acquisition, new modernization services, and executive equity awards; none was announced on August 24.
- Technology shares are broadly weaker, so the move remains unexplained and may reflect stock-specific trading flows.